PPI-1019

PPI-1019 · PRAECIS Pharmaceuticals Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for PPI-1019, covering 2006-09-19 to 2006-09-19. Get the full timeline:

Most recent: Clinical Trial Update: Safety Study of PPI-1019 in Subjects With Mild-Moderate Alzheimer's Disease [Phase 1, Phase 2]